EU Approves TEPKINLY® for Relapsed/Refractory Follicular Lymphoma

New IAEA Project to Advance Terbium-Based Radiopharmaceuticals for Improved Theranostics MedEdge MEA

Theranostic radiopharmaceuticals, which combine diagnosis and therapy within a single administration, are transforming the management of cancer and other diseases.   T...

Read More
Biegler GmbH - We Provide Innovative, High-Quality Solutions for the Medical Profession Infomedix International

Biegler Medizinelektronik, based in Austria/Europe, has to its credit more than 40 years of research, development and production in the service of medicine. Customers are...

Read More
BD Completes Acquisition of Critical Care from Edwards Lifesciences MedEdge MEA

BD announced it has completed the acquisition of Edwards Lifesciences’ Critical Care product group, which will be renamed as BD Advanced Patient Monitoring. BD Advance...

Read More
EU Approves TEPKINLY® for Relapsed/Refractory Follicular Lymphoma MedEdge MEA

AbbVie recently announced that the European Commission (EC) has granted conditional marketing authorization for TEPKINLY® (epcoritamab) as a monotherapy for the treatment...

Read More
Menu
Categories
How does it work